AAAAAA

   
Results: 1-12 |
Results: 12
Prolonged molecular and clinical remission after treatment of a patient with follicular lymphoma with rituximab
Authors: Buckstein, RJ Rimrie, K Pennell, N Spaner, D Hewitt, K Berinstein, NL
Citation: Rj. Buckstein et al., Prolonged molecular and clinical remission after treatment of a patient with follicular lymphoma with rituximab, LEUK LYMPH, 41(3-4), 2001, pp. 451-455
ALVAC-mediated gene transfer is efficient in lymphoid malignancies of T-and early B-cell origin, but not in tumors arising from mature B-cells
Authors: Gitelson, E Ghose, A Buckstein, R Imrie, K Lim, MS Reis, M Spaner, D Tartaglia, J Berinstein, NL
Citation: E. Gitelson et al., ALVAC-mediated gene transfer is efficient in lymphoid malignancies of T-and early B-cell origin, but not in tumors arising from mature B-cells, CANCER IMMU, 50(7), 2001, pp. 345-355
4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors
Authors: Guinn, BA Bertram, EM DeBenedette, MA Berinstein, NL Watts, TH
Citation: Ba. Guinn et al., 4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors, CELL IMMUN, 210(1), 2001, pp. 56-65
Immunogenicity of whole-cell tumor preparations infected with the ALVAC viral vector
Authors: Ghose, A Iakhnina, E Spaner, D Tartaglia, J Berinstein, NL
Citation: A. Ghose et al., Immunogenicity of whole-cell tumor preparations infected with the ALVAC viral vector, HUM GENE TH, 11(9), 2000, pp. 1289-1301
Functional analysis of the human RAG 2 promoter
Authors: Fong, IC Zarrin, AA Wu, GE Berinstein, NL
Citation: Ic. Fong et al., Functional analysis of the human RAG 2 promoter, MOL IMMUNOL, 37(7), 2000, pp. 391-402
Molecular diagnostics in follicular non-Hodgkin's lymphoma: A review
Authors: Bordeleau, L Berinstein, NL
Citation: L. Bordeleau et Nl. Berinstein, Molecular diagnostics in follicular non-Hodgkin's lymphoma: A review, SEMIN ONCOL, 27(6), 2000, pp. 42-52
Characterization of the human B cell RAG-associated gene, hBRAG, as a B cell receptor signal-enhancing glycoprotein dimer that associates with phosphorylated proteins in resting B cells
Authors: Verkoczy, LK Guinn, B Berinstein, NL
Citation: Lk. Verkoczy et al., Characterization of the human B cell RAG-associated gene, hBRAG, as a B cell receptor signal-enhancing glycoprotein dimer that associates with phosphorylated proteins in resting B cells, J BIOL CHEM, 275(28), 2000, pp. 20967-20979
Mitoxantrone-DHAP with GM-CSF: an active but myelosuppressive salvage therapy for relapsed/refractory aggressive non-Hodgkin's lymphoma
Authors: Haq, R Sawka, CA Franssen, E Berinstein, NL
Citation: R. Haq et al., Mitoxantrone-DHAP with GM-CSF: an active but myelosuppressive salvage therapy for relapsed/refractory aggressive non-Hodgkin's lymphoma, LEUK LYMPH, 35(5-6), 1999, pp. 527-536
Delivery of full dose CHOP chemotherapy to elderly patients with aggressive non-Hodgkin's lymphoma without G-CSF support
Authors: Campbell, C Sawka, C Franssen, E Berinstein, NL
Citation: C. Campbell et al., Delivery of full dose CHOP chemotherapy to elderly patients with aggressive non-Hodgkin's lymphoma without G-CSF support, LEUK LYMPH, 35(1-2), 1999, pp. 119-127
Comparison of CMV, RSV, SV40 viral and V lambda 1 cellular promoters in B and T lymphoid and non-lymphoid cell lines
Authors: Zarrin, AA Malkin, L Fong, I Luk, KD Ghose, A Berinstein, NL
Citation: Aa. Zarrin et al., Comparison of CMV, RSV, SV40 viral and V lambda 1 cellular promoters in B and T lymphoid and non-lymphoid cell lines, BBA-GENE ST, 1446(1-2), 1999, pp. 135-139
Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-gradenon-Hodgkin's lymphoma
Authors: Buckstein, R Imrie, K Spaner, D Potichnyj, A Robinson, JB Nanji, S Pennel, N Reis, M Pinkerton, P Dube, I Hewitt, K Berinstein, NL
Citation: R. Buckstein et al., Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-gradenon-Hodgkin's lymphoma, SEMIN ONCOL, 26(5), 1999, pp. 115-122
4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine
Authors: Guinn, B DeBenedette, MA Watts, TH Berinstein, NL
Citation: B. Guinn et al., 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine, J IMMUNOL, 162(8), 1999, pp. 5003-5010
Risultati: 1-12 |